← Eichor
Condition: Toxicities Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Toxicities

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · 590 location(s) · SWOG Cancer Research Network · NCT03418961Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients
NA · 1 location(s) · Dena h. Al-Tameemi · NCT07273812Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigatin
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT06909201Cardiovascular Health in Adult Patients With Cancer Exposed to Cardiotoxic Therapies
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06664528Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibi
Phase N/A · 6 location(s) · Shantou University Medical College · NCT07357636Predictive Toxicity Test Linked to Radiotherapy After Mastectomy and Immediate Implant Reconstruction
NA · 9 location(s) · Institut du Cancer de Montpellier - Val d'Aurelle · NCT04342546A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer.
NA · 1 location(s) · CHU de Quebec-Universite Laval · NCT06052683Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2022 and 2025
Phase N/A · 1 location(s) · Bernardino Clavo, MD, PhD · NCT05417737Efficacy and Toxicity of Total Neoadjuvant Sandwich Treatment Via Short Course Radiotherapy in the Treatment of Stage II
Phase 2 · 1 location(s) · Ain Shams University · NCT07095439Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Horm
Phase N/A · 1 location(s) · University Hospital, Brest · NCT06621459Photobiomodulation Therapy in the Management of Hand-foot Syndrome and Hand-foot Skin Reaction
NA · 2 location(s) · Jessa Hospital · NCT04979078A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immu
Phase 2 · 11 location(s) · Canadian Cancer Trials Group · NCT03847649Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer:
Phase N/A · 1 location(s) · Fundación Pública Andaluza para la Investigación Biomédica A · NCT07582887Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therap
NA · 1 location(s) · The Cooper Health System · NCT06688422Oxygen Toxicity: Mechanisms in Humans
NA · 1 location(s) · Duke University · NCT05761756Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabol
Phase 2 · 1 location(s) · City of Hope Medical Center · NCT07202247Tessa Jowell BRAIN MATRIX - Platform Study
Phase N/A · 14 location(s) · University of Birmingham · NCT04274283Standard Follow-up Program (SFP) for Lung Cancer Patients Treated With Radiotherapy or Chemoradiation
Phase N/A · 1 location(s) · University Medical Center Groningen · NCT02421718GALENOS 1 in Head and Neck, Lung, and Rectal Cancer Patients
Phase N/A · 1 location(s) · Fondazione del Piemonte per l'Oncologia · NCT07511413Trastuzumab Deruxtecan in First-Line HER2-Positive Metastatic Breast Cancer With Proactive Toxicity Management
Phase 2 · 27 location(s) · SOLTI Breast Cancer Research Group · NCT07371585Salvage Ultrahypofractionated Postoperative External Radiotherapy For Biochemical Recurrence
Phase N/A · 1 location(s) · University of Milano Bicocca · NCT06941363RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer
Phase 1/Phase 2 · 3 location(s) · Georgetown University · NCT05256745Predictive Value of CRP, Albumin, CAR, and mGPS in Treatment Outcomes of DLBCL
Phase N/A · 1 location(s) · Ain Shams University · NCT07057765Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT07215611ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0
Phase N/A · 1 location(s) · University of Milano Bicocca · NCT07407608Cardiotoxicity of Carbon Monoxide in Patients Treated With Hyperbaric Oxygen Therapy
Phase N/A · 1 location(s) · University Hospital, Brest · NCT06549621Chronic Toxicities Related to Treatment in Patients With Localized Cancer
NA · 1 location(s) · UNICANCER · NCT01993498Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy
Phase 2 · 1 location(s) · Ruijin Hospital · NCT06589089Gut Microbiome Profiles in Patients with Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).
Phase 2/Phase 3 · 1 location(s) · Bernardino Clavo, MD, PhD · NCT06799351Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Phase N/A · 849 location(s) · SWOG Cancer Research Network · NCT04871542
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.